Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcription factors and asthma

P J Barnes1, I M Adcock

  • 1Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London, UK.

The European Respiratory Journal
|August 13, 1998
PubMed
Summary

Transcription factors orchestrate gene expression in asthma. Understanding their interactions, like NF-kappaB and AP-1, offers new therapeutic targets for this chronic inflammatory disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026
Same author

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026
Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026
Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025
Same author

The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2024
Same author

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

Allergy·2023

Area of Science:

  • * Molecular biology and immunology.
  • * Focus on gene regulation in respiratory diseases.

Background:

  • * Asthma involves complex gene expression of inflammatory proteins.
  • * Transcription factors (TFs) control these genes, activated by inflammatory signals.
  • * Key TFs in asthma include NF-kappaB, AP-1, NF-AT, CREB, and STAT.

Purpose of the Study:

  • * To explore the role of transcription factors in asthma pathogenesis.
  • * To understand TF interactions and their impact on inflammatory gene expression.
  • * To highlight TFs as potential targets for asthma therapy.

Main Methods:

  • * Review of scientific literature on transcription factors and asthma.
  • * Analysis of TF involvement in inflammatory gene regulation.
  • * Examination of TF interactions and co-activator roles.

Main Results:

  • * Synergistic interactions between TFs (e.g., NF-kappaB and AP-1) drive specific inflammatory patterns in asthma.
  • * Corticosteroids function as transcription factors, inhibiting inflammatory actions.
  • * Co-activators like CREB-binding protein (CBP) play a crucial role in TF coordination and gene transcription.

Conclusions:

  • * Transcription factors are central to the chronic inflammation seen in asthma.
  • * Understanding TF mechanisms provides insights into corticosteroid action.
  • * Targeting transcription factors may lead to novel asthma treatments.

Related Experiment Videos